These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22153775)

  • 1. Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies.
    Brezinova J; Zemanova Z; Bystricka D; Sarova I; Lizcova L; Malinova E; Izakova S; Sajdova J; Sponerova D; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2012 Mar; 36(3):e43-5. PubMed ID: 22153775
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome abnormalities in acute myeloid leukemia: a cytogenetic study in an Indonesian population.
    Sudoyo AW; Indahwati ; Djoerban Z; Abdulmuthalib ; Reksodiputro AH
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():482-90. PubMed ID: 10895199
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of atypical myeloproliferative disorder transformed to acute myeloid leukemia with monosomy 7].
    Takai K; Sanada M; Honma K
    Rinsho Ketsueki; 1988 Feb; 29(2):221-6. PubMed ID: 3164423
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
    Jarosova M; Nedomova R; Hubacek J; Holzerova M; Mickova P; Katrincsakova B; Pikalova Z; Papajik T; Indrak K
    Leuk Res; 2012 Apr; 36(4):e68-70. PubMed ID: 22284693
    [No Abstract]   [Full Text] [Related]  

  • 6. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
    MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
    Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
    Bram S; Rödjer S; Swolin B
    Cancer Genet Cytogenet; 2004 Nov; 155(1):74-8. PubMed ID: 15527906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of chromosome arm 15q in a case of minimally differentiated hypoplastic AML-M0.
    Fujieda A; Masuya M; Kitano S; Miyazaki K; Yazaki A; Sugimoto Y; Usui E; Miyata E; Shibasaki T; Yamamura K; Ohishi K; Nishii K; Nakase K; Takeuchi T; Katayama N
    Cancer Genet Cytogenet; 2008 Jul; 184(1):57-61. PubMed ID: 18558291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies.
    Giagounidis AA; Germing U; Aul C
    Clin Cancer Res; 2006 Jan; 12(1):5-10. PubMed ID: 16397017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
    Struski S; Luquet I
    Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
    Gao Q; Horwitz M; Roulston D; Hagos F; Zhao N; Freireich EJ; Golomb HM; Olopade OI
    Genes Chromosomes Cancer; 2000 Jun; 28(2):164-72. PubMed ID: 10825001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC; Ma ES; Wan TS; Yip SF; Chan LC
    Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization.
    Shipley J; Weber-Hall S; Birdsall S
    Genes Chromosomes Cancer; 1996 Mar; 15(3):182-6. PubMed ID: 8721684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic manifestation of chromosome 11 duplication/amplification in acute myeloid leukemia.
    Sárová I; Brezinová J; Zemanová Z; Izáková S; Lizcová L; Malinová E; Berková A; Cermák J; Maaloufová J; Nováková L; Michalová K
    Cancer Genet Cytogenet; 2010 Jun; 199(2):121-7. PubMed ID: 20471515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 7q31.1 deletion in myeloid neoplasms.
    Tripputi P; Bianchi P; Fermo E; Bignotto M; Zanella A
    Hum Pathol; 2014 Feb; 45(2):368-71. PubMed ID: 24439223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.